Moderna's gains expand to 150%, hitting a new high since June 2024
2026-08-19 14:23
Odaily News: According to MSX.COM data, Moderna's gains expanded to 150%, reaching a new high since June 2024. On the news front, the company, together with Merck, announced that their melanoma skin cancer vaccine met its goals in a large-scale trial.
